| 000 | 01856 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517052957.0 | ||
| 264 | 0 | _c20160822 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.5610 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhu, Gui-Qi | |
| 245 | 0 | 0 |
_aA network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. _h[electronic resource] |
| 260 |
_bOncotarget _cSep 2015 |
||
| 300 |
_a26757-69 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
| 650 | 0 | 4 |
_aBilirubin _xblood |
| 650 | 0 | 4 |
_aCholagogues and Choleretics _xadministration & dosage |
| 650 | 0 | 4 |
_aCholangitis, Sclerosing _xtherapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xpathology |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 |
_aMetronidazole _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrsodeoxycholic Acid _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aShi, Ke-Qing | |
| 700 | 1 | _aHuang, Gui-Qian | |
| 700 | 1 | _aWang, Li-Ren | |
| 700 | 1 | _aLin, Yi-Qian | |
| 700 | 1 | _aBraddock, Martin | |
| 700 | 1 | _aChen, Yong-Ping | |
| 700 | 1 | _aZhou, Meng-Tao | |
| 700 | 1 | _aZheng, Ming-Hua | |
| 773 | 0 |
_tOncotarget _gvol. 6 _gno. 29 _gp. 26757-69 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.5610 _zAvailable from publisher's website |
| 999 |
_c25268923 _d25268923 |
||